BIIB | Biogen Inc. Common Stock | $36.8b | $253.00 | +0.2% | 281.0K |
NBIX | Neurocrine Biosciences Inc | $16.8b | $166.03 | -0.7% | 539.8K |
JAZZ | Jazz Pharmaceuticals, Inc. | $14.9b | $242.97 | +0.8% | 149.8K |
TGTX | TG Therapeutics, Inc. | $9.3b | $62.91 | -2.4% | 713.6K |
CYTK | Cytokinetics Inc. | $8.7b | $53.09 | -4.9% | 604.2K |
PRAX | Praxis Precision Medicines, Inc. Common Stock | $7.8b | $308.32 | -6.2% | 332.3K |
ALKS | Alkermes Inc. plc | $7.7b | $46.89 | -0.3% | 331.8K |
AXSM | Axsome Therapeutics, Inc | $7.3b | $138.26 | -2.4% | 304.1K |
PTCT | PTC Therapeutics, Inc. | $5.7b | $61.64 | -2.6% | 181.5K |
DFTX | Definium Therapeutics, Inc. Common Shares | $4.5b | $30.35 | -5.5% | 587.6K |
INDV | Indivior Pharmaceuticals, Inc. Common Stock | $4.2b | $36.40 | 0.0% | N/A |
XENE | Xenon Pharmaceuticals Inc | $3.7b | $39.53 | -2.3% | 471.0K |
AMLX | Amylyx Pharmaceuticals, Inc. Common Stock | $3.7b | $28.60 | -5.9% | 683.8K |
ACAD | Acadia Pharmaceuticals Inc. | $3.5b | $19.24 | +2.6% | 750.5K |
DNLI | Denali Therapeutics Inc. Common Stock | $3.1b | $18.45 | -1.4% | 376.8K |
RGC | Regencell Bioscience Holdings Limited Ordinary Shares | $3.0b | $4.69 | -4.3% | 69.3K |
ATAI | AtaiBeckley Inc. Common Stock | $2.7b | $7.33 | 0.0% | N/A |
BHVN | Biohaven Ltd. | $2.4b | $13.91 | +0.1% | 885.1K |
HRMY | Harmony Biosciences Holdings, Inc. Common Stock | $2.2b | $33.17 | -1.7% | 326.1K |
STOK | Stoke Therapeutics, Inc. Common Stock | $1.7b | $26.56 | -0.3% | 166.2K |
SUPN | Supernus, Inc. Common Stock | $1.6b | $28.88 | -2.7% | 2.0M |
RAPP | Rapport Therapeutics, Inc. Common Stock | $1.4b | $25.16 | -5.1% | 119.1K |
GHRS | GH Research PLC Ordinary Shares | $1.4b | $18.71 | -1.9% | 265.4K |
TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.3b | $4.00 | -2.2% | 831.8K |
LBRX | LB Pharmaceuticals Inc Common Stock | $1.3b | $42.60 | -1.4% | 285.5K |
SPTX | Seaport Therapeutics, Inc. Common Stock | $1.2b | $19.30 | -3.4% | 211.1K |
ANRO | Alto Neuroscience Inc. | $0.9b | $27.96 | -5.9% | 352.0K |
TBPH | Theravance Biopharma, Inc. | $0.9b | $17.05 | 0.0% | N/A |
ALMS | Alumis Inc. Common Stock | $0.8b | $5.05 | -9.9% | 1.0M |
ANNX | Annexon, Inc. Common Stock | $0.8b | $3.63 | -7.7% | 1.7M |
COLL | Collegium Pharmaceutical, Inc. Common Stock | $0.8b | $25.24 | -0.2% | 163.3K |
HELP | Helus Pharma Inc. Common Stock | $0.7b | $8.09 | -10.0% | 11.5M |
AQST | Aquestive Therapeutics, Inc. Common Stock | $487.0m | $3.76 | -4.2% | 1.2M |
OVID | Ovid Therapeutics Inc. Common Stock | $468.7m | $2.58 | +2.2% | 1.2M |
RLMD | Relmada Therapeutics, Inc. Common Stock | $455.5m | $3.52 | -16.5% | 1.1M |
PRTA | Prothena Corporation plc Ordinary Shares | $421.5m | $7.92 | -2.8% | 104.7K |
MPLT | MapLight Therapeutics, Inc. Common Stock | $378.5m | $6.97 | -4.1% | 149.7K |
CTNM | Contineum Therapeutics, Inc. Class A Common Stock | $364.5m | $9.49 | -2.6% | 127.8K |
ALEC | Alector, Inc. Common Stock | $228.9m | $2.55 | +0.6% | 980.1K |
VNDA | Vanda Pharmaceuticals Inc. | $226.8m | $3.77 | -5.1% | 412.2K |
ELDN | Eledon Pharmaceuticals, Inc. Common Stock | $212.9m | $2.00 | -5.7% | 650.3K |
DRUG | Bright Minds Biosciences Inc. Common Stock | $212.6m | $23.84 | +1.9% | 73.7K |
ACIU | AC Immune SA | $207.8m | $2.06 | -4.0% | 43.6K |
IKT | Inhibikase Therapeutics, Inc. Common Stock | $206.5m | $1.48 | -3.3% | 142.6K |
ACOG | Alpha Cognition Inc. Common Stock | $178.6m | $7.82 | -4.7% | 115.7K |
PEPG | PepGen Inc. Common Stock | $170.4m | $4.17 | -3.7% | 1.6M |
NGEN | NervGen Pharma Corp. Common stock | $141.9m | $1.89 | -0.5% | 1.3M |
VYGR | Voyager Therapeutics, Inc. Common Stock | $112.8m | $1.67 | -4.0% | 277.6K |
NERV | Minerva Neurosciences, Inc | $112.2m | $2.23 | -1.7% | 69.5K |
AVXL | Anavex Life Sciences | $111.2m | $0.84 | -10.0% | 1.2M |